Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LABS.TO Stock Summary
In the News
LABS.TO Financial details
Company Rating
Neutral
Market Cap
34.11M
Income
-15.73M
Revenue
29.55M
Book val./share
0.13
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
130
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-2.06
Forward P/E
8
PEG
0.26
P/S
0.95
P/B
0.59
P/C
2.67
P/FCF
-1.92
Quick Ratio
2.11
Current Ratio
3.27
Debt / Equity
0.05
LT Debt / Equity
0
-
-
EPS (TTM)
-0.05
EPS next Y
0.01
EPS next Q
-0.01
EPS this Y
-50%
EPS next Y
-125.1%
EPS next 5Y
-876.36%
EPS last 5Y
-1.73%
Revenue last 5Y
16.75%
Revenue Q/Q
-11.25%
EPS Q/Q
44.93%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-23%
ROE
-28%
ROC
-0.35%
Gross Margin
13%
Oper. Margin
-66%
Profit Margin
-53%
Payout
-
Shs Outstand
401.28M
Shs Float
384.5M
-
-
-
-
Target Price
-
52W Range
0.055-0.1
52W High
-
52W Low
-
RSI
57
Rel Volume
2.17
Avg Volume
174.58K
Volume
378.75K
Perf Week
23.08%
Perf Month
14.29%
Perf Quarter
6.67%
Perf Half Y
0%
-
-
-
-
Beta
1.045
-
-
Volatility
0.01%, 0.01%
Prev Close
-11.11%
Price
0.08
Change
-15.79%
LABS.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.15 | 0.96 | 0.26 | 0.09 | 0.08 | |
Net income per share | -0.12 | 0.01 | -0.48 | -0.22 | -0.11 | |
Operating cash flow per share | -0.16 | -0.19 | -0.27 | -0.05 | -0.06 | |
Free cash flow per share | -0.37 | -0.43 | -0.33 | -0.06 | -0.06 | |
Cash per share | 0.12 | 0.29 | 0.16 | 0.14 | 0.09 | |
Book value per share | 0.4 | 0.98 | 0.57 | 0.33 | 0.2 | |
Tangible book value per share | 0.4 | 0.97 | 0.56 | 0.33 | 0.2 | |
Share holders equity per share | 0.4 | 0.98 | 0.57 | 0.33 | 0.2 | |
Interest debt per share | 0.09 | 0.08 | 0.19 | 0.04 | 0 | |
Market cap | 221.53M | 519.67M | 73.43M | 46.23M | 19.38M | |
Enterprise value | 219.68M | 491.62M | 71.98M | 12.34M | -4.13M | |
P/E ratio | -26.34 | 459.48 | -1.09 | -0.84 | -0.65 | |
Price to sales ratio | 21.72 | 4.02 | 2.04 | 2.13 | 0.88 | |
POCF ratio | -19.93 | -20.57 | -1.94 | -3.5 | -1.21 | |
PFCF ratio | -8.62 | -9.01 | -1.62 | -3.3 | -1.14 | |
P/B Ratio | 8.01 | 3.95 | 0.94 | 0.56 | 0.35 | |
PTB ratio | 8.01 | 3.95 | 0.94 | 0.56 | 0.35 | |
EV to sales | 21.54 | 3.8 | 2 | 0.57 | -0.19 | |
Enterprise value over EBITDA | -30.96 | 49.38 | -1.2 | -0.33 | 0.16 | |
EV to operating cash flow | -19.77 | -19.46 | -1.91 | -0.93 | 0.26 | |
EV to free cash flow | -8.55 | -8.52 | -1.59 | -0.88 | 0.24 | |
Earnings yield | -0.04 | 0 | -0.91 | -1.19 | -1.55 | |
Free cash flow yield | -0.12 | -0.11 | -0.62 | -0.3 | -0.87 | |
Debt to equity | 0.22 | 0.08 | 0.24 | 0 | 0.01 | |
Debt to assets | 0.14 | 0.06 | 0.16 | 0 | 0.01 | |
Net debt to EBITDA | 0.26 | -2.82 | 0.02 | 0.91 | 0.92 | |
Current ratio | 1.79 | 4.15 | 3.36 | 7.38 | 5.01 | |
Interest coverage | -22.05 | 10.32 | -9.22 | -4.66 | -952.68 | |
Income quality | 1.31 | -22.34 | 0.56 | 0.24 | 0.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.54 | 0.24 | 0.68 | 0.85 | 0.83 | |
Research and developement to revenue | 0.03 | 0.01 | 0.06 | 0.06 | 0.05 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 1.31 | 1.28 | 0.2 | 0.06 | 0.05 | |
Capex to revenue | -1.43 | -0.25 | -0.21 | -0.04 | -0.04 | |
Capex to depreciation | -14.84 | -12.82 | -0.69 | -0.14 | -0.3 | |
Stock based compensation to revenue | 0.19 | 0.12 | 0.07 | 0.11 | 0.13 | |
Graham number | 1.04 | 0.43 | 2.48 | 1.28 | 0.7 | |
ROIC | -0.24 | 0.01 | -0.69 | -0.59 | -0.52 | |
Return on tangible assets | -0.2 | 0.01 | -0.57 | -0.59 | -0.46 | |
Graham Net | 0.04 | 0.36 | 0.14 | 0.18 | 0.11 | |
Working capital | 11.73M | 90.86M | 57.28M | 56.67M | 37.89M | |
Tangible asset value | 27.84M | 131.23M | 78.19M | 83.1M | 55.97M | |
Net current asset value | 11.73M | 82.1M | 41.7M | 56.33M | 37.86M | |
Invested capital | 0.22 | 0.08 | 0.24 | 0 | 0.01 | |
Average receivables | 3.21M | 16.98M | 31.21M | 26.11M | 15.25M | |
Average payables | 4M | 13.52M | 12.3M | 4.27M | 3.27M | |
Average inventory | 4.7M | 30.45M | 36.81M | 16.56M | 9.38M | |
Days sales outstanding | 230.03 | 77.77 | 353.49 | 291.7 | 217.03 | |
Days payables outstanding | 468.16 | 80.56 | 25.32 | 29.54 | 53.75 | |
Days of inventory on hand | 550.87 | 217.66 | 101.02 | 108.4 | 118.11 | |
Receivables turnover | 1.59 | 4.69 | 1.03 | 1.25 | 1.68 | |
Payables turnover | 0.78 | 4.53 | 14.42 | 12.36 | 6.79 | |
Inventory turnover | 0.66 | 1.68 | 3.61 | 3.37 | 3.09 | |
ROE | -0.3 | 0.01 | -0.86 | -0.66 | -0.54 | |
Capex per share | -0.21 | -0.24 | -0.05 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Net income per share | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 | |
Operating cash flow per share | -0.01 | 0 | -0.01 | -0.02 | -0.01 | |
Free cash flow per share | -0.01 | 0 | -0.01 | -0.02 | -0.01 | |
Cash per share | 0.07 | 0.09 | 0.07 | 0.04 | 0.03 | |
Book value per share | 0.23 | 0.2 | 0.19 | 0.15 | 0.13 | |
Tangible book value per share | 0.23 | 0.2 | 0.19 | 0.15 | 0.13 | |
Share holders equity per share | 0.23 | 0.2 | 0.19 | 0.15 | 0.13 | |
Interest debt per share | 0 | 0 | 0 | 0.01 | 0.01 | |
Market cap | 18.5M | 19.38M | 19.75M | 21.46M | 32.45M | |
Enterprise value | 218.33K | -4.13M | -180.46K | 9.63M | 22.22M | |
P/E ratio | -0.59 | -0.86 | -1.6 | -1.98 | -1.88 | |
Price to sales ratio | 2.55 | 3.45 | 3.38 | 2.24 | 3.82 | |
POCF ratio | -6.41 | -115.36 | -6.47 | -2.85 | -10.04 | |
PFCF ratio | -5.78 | -40.63 | -6.42 | -2.82 | -9.29 | |
P/B Ratio | 0.31 | 0.35 | 0.37 | 0.36 | 0.59 | |
PTB ratio | 0.31 | 0.35 | 0.37 | 0.36 | 0.59 | |
EV to sales | 0.03 | -0.74 | -0.03 | 1 | 2.61 | |
Enterprise value over EBITDA | -0.03 | 1.21 | 0.07 | -1.43 | -6.24 | |
EV to operating cash flow | -0.08 | 24.6 | 0.06 | -1.28 | -6.88 | |
EV to free cash flow | -0.07 | 8.66 | 0.06 | -1.27 | -6.36 | |
Earnings yield | -0.42 | -0.29 | -0.16 | -0.13 | -0.13 | |
Free cash flow yield | -0.17 | -0.02 | -0.16 | -0.35 | -0.11 | |
Debt to equity | 0.02 | 0.01 | 0 | 0.05 | 0.05 | |
Debt to assets | 0.02 | 0.01 | 0 | 0.04 | 0.04 | |
Net debt to EBITDA | 2.55 | 6.88 | 7.69 | 1.75 | 2.87 | |
Current ratio | 4.87 | 5.01 | 5.3 | 3.68 | 3.27 | |
Interest coverage | -502.88 | -417.2 | -666.6 | -69.35 | -29.23 | |
Income quality | 0.36 | 0.03 | 0.99 | 2.79 | 0.75 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.68 | 0.39 | 0.67 | 0.55 | |
Research and developement to revenue | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.02 | |
Capex to operating cash flow | 0.11 | 1.84 | 0.01 | 0.01 | 0.08 | |
Capex to revenue | -0.04 | -0.06 | 0 | -0.01 | -0.03 | |
Capex to depreciation | -0.42 | -0.57 | -0.05 | -0.1 | -0.42 | |
Stock based compensation to revenue | 0.02 | 0.25 | 0.13 | 0.06 | 0.05 | |
Graham number | 0.39 | 0.3 | 0.22 | 0.15 | 0.17 | |
ROIC | -0.13 | -0.07 | -0.07 | -0.13 | -0.07 | |
Return on tangible assets | -0.11 | -0.09 | -0.05 | -0.04 | -0.06 | |
Graham Net | 0.09 | 0.11 | 0.09 | 0.05 | 0.04 | |
Working capital | 41.48M | 37.89M | 36M | 34.02M | 28.95M | |
Tangible asset value | 60.44M | 55.97M | 53.63M | 58.13M | 54.13M | |
Net current asset value | 41.43M | 37.86M | 35.98M | 32.19M | 28.87M | |
Invested capital | 0.02 | 0.01 | 0 | 0.05 | 0.05 | |
Average receivables | 14.26M | 13.44M | 13.46M | 14.59M | 14.67M | |
Average payables | 3.61M | 3.62M | 2.96M | 3.06M | 3.07M | |
Average inventory | 11.43M | 8.54M | 7.95M | 9.73M | 10.86M | |
Days sales outstanding | 170.23 | 210.75 | 212.15 | 144.76 | 147.46 | |
Days payables outstanding | 39.34 | 58.93 | 39.41 | 38.38 | 35.8 | |
Days of inventory on hand | 99.03 | 129.48 | 134.01 | 116.81 | 153.7 | |
Receivables turnover | 0.53 | 0.43 | 0.42 | 0.62 | 0.61 | |
Payables turnover | 2.29 | 1.53 | 2.28 | 2.34 | 2.51 | |
Inventory turnover | 0.91 | 0.7 | 0.67 | 0.77 | 0.59 | |
ROE | -0.13 | -0.1 | -0.06 | -0.05 | -0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
LABS.TO Frequently Asked Questions
What is MediPharm Labs Corp. stock symbol ?
MediPharm Labs Corp. is a CA stock , located in Barrie of On and trading under the symbol LABS.TO
What is MediPharm Labs Corp. stock quote today ?
MediPharm Labs Corp. stock price is $0.08 today.
Is MediPharm Labs Corp. stock public?
Yes, MediPharm Labs Corp. is a publicly traded company.